Strategic partnership Leverage recent exclusivity agreement with Legacy Medical Consultants to pursue expansion into the U.S. market for ActiGraft Pro, targeting chronic wound care facilities, hospitals, and long-term care networks.

Global footprint Capitalize on dual US-Israel presence to approach multinational medical device distributors and healthcare systems, highlighting autologous, patient-derived healing technologies as a differentiator in wound care portfolios.

Product evolution Position ActiGraft Pro and ActiGraft+ as a scalable wound management platform to drive bundled proposals with consumables and services, appealing to Wound Care Centers of Excellence seeking innovative solutions.

Funding halo Use the recent Series D funding and high-profile investors to validate credibility with potential customers and lenders, enabling early-adopter programs and joint marketing opportunities with partners.

Market timing Target growth in chronic wound care demand by aligning sales efforts with attending SAWC and AHCA/NCAL events, and offering pilot programs, training, and data partnerships to accelerate adoption.